Franklin Park, NJ, United States of America

Zhixin Zong

This inventor holds 7 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Purdue Pharma L.p., Novartis Ag. Active years: 2017-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhixin Zong. Retrieved from https://idiyas.com/inventor/zhixin-zong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 (Patent Applications = 7)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 7)

EPO Patents = 2 (Patent Applications = 10)

Average Co-Inventor Count = 4.2

ph-index = 2

Forward Citations = 8(Granted Patents)

Company Filing History:

Years Active: 2017-2025

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12208101 - Tablet formulation of 2-fluoro-n-methyl-4-[7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide (2025-01-28),

2. 10751287 - Tamper resistant pharmaceutical formulations (2020-08-25),

3. 10596178 - Tablet formulation of 2-fluoro-N-methyl-4-[7-(quinolin-6-ylmethyl) imidazo [1,2-B] [1,2,4] triazin-2-yl] benzamide (2020-03-24),

4. 10517832 - Tamper resistant pharmaceutical formulations (2019-12-31),

5. 10195152 - Tamper resistant pharmaceutical formulations (2019-02-05),

6. 10085993 - Tablet formulation of 2-fluoro-N-methyl-4-[ 7-( quinolin-6-ylmethyl) imidazo [1,2-B] [1,2,4] triazin-2-yl] benzamide (2018-10-02),

7. 9616030 - Tamper resistant pharmaceutical formulations (2017-04-11),

Title: Zhixin Zong: Innovator in Pharmaceutical Formulations

Introduction

Zhixin Zong is a notable inventor based in Franklin Park, NJ (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 7 patents. His work primarily focuses on innovative tablet formulations aimed at treating various medical conditions.

Latest Patents

Among his latest patents is a formulation for tablets containing 2-fluoro-N-methyl-4-[7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide. This invention relates to tablets that incorporate this compound, detailing processes for their production and their applications in cancer treatment. Another significant patent is for tamper-resistant pharmaceutical formulations. This patent describes a solid oral dosage form that includes particles with an active agent susceptible to abuse, designed to enhance safety and efficacy.

Career Highlights

Zhixin Zong has worked with prominent companies in the pharmaceutical industry, including Purdue Pharma L.P. and Novartis AG. His experience in these organizations has allowed him to develop and refine his innovative ideas in drug formulation.

Collaborations

Throughout his career, Zong has collaborated with various professionals, including Rama Abu Shmeis and Sheetal Muley, who have contributed to his projects and research endeavors.

Conclusion

Zhixin Zong's contributions to pharmaceutical innovations highlight his expertise and commitment to improving medical treatments. His patents reflect a dedication to addressing critical health challenges through advanced formulations.

Profile summary based on public USPTO records.